Article Type
Changed
Thu, 12/15/2022 - 18:36

Key clinical point: The presence of sarcopenic obesity (SO) increases the risk for severe postoperative complications and worse survival outcomes in patients who have undergone gastrectomy for gastric cancer.

Major finding: SO was associated with an increased risk for serious Clavien-Dindo complications grade >IIIb/IV (odds ratio 2.82; P = .028) and worse overall survival (adjusted hazard ratio 0.45; P = .026) after gastrectomy.

Study details: This single-center retrospective study included 190 patients with gastric cancer who had undergone curative-intent gastrectomy, of which 40 patients had SO.

Disclosures: This study did not report the source of funding. The authors declared no conflicts of interest.

Source: Juez LD et al. Impact of sarcopenic obesity on long-term cancer outcomes and postoperative complications after gastrectomy for gastric cancer. J Gastrointest Surg. 2022 (Nov 2). Doi: 10.1007/s11605-022-05492-w

Publications
Topics
Sections

Key clinical point: The presence of sarcopenic obesity (SO) increases the risk for severe postoperative complications and worse survival outcomes in patients who have undergone gastrectomy for gastric cancer.

Major finding: SO was associated with an increased risk for serious Clavien-Dindo complications grade >IIIb/IV (odds ratio 2.82; P = .028) and worse overall survival (adjusted hazard ratio 0.45; P = .026) after gastrectomy.

Study details: This single-center retrospective study included 190 patients with gastric cancer who had undergone curative-intent gastrectomy, of which 40 patients had SO.

Disclosures: This study did not report the source of funding. The authors declared no conflicts of interest.

Source: Juez LD et al. Impact of sarcopenic obesity on long-term cancer outcomes and postoperative complications after gastrectomy for gastric cancer. J Gastrointest Surg. 2022 (Nov 2). Doi: 10.1007/s11605-022-05492-w

Key clinical point: The presence of sarcopenic obesity (SO) increases the risk for severe postoperative complications and worse survival outcomes in patients who have undergone gastrectomy for gastric cancer.

Major finding: SO was associated with an increased risk for serious Clavien-Dindo complications grade >IIIb/IV (odds ratio 2.82; P = .028) and worse overall survival (adjusted hazard ratio 0.45; P = .026) after gastrectomy.

Study details: This single-center retrospective study included 190 patients with gastric cancer who had undergone curative-intent gastrectomy, of which 40 patients had SO.

Disclosures: This study did not report the source of funding. The authors declared no conflicts of interest.

Source: Juez LD et al. Impact of sarcopenic obesity on long-term cancer outcomes and postoperative complications after gastrectomy for gastric cancer. J Gastrointest Surg. 2022 (Nov 2). Doi: 10.1007/s11605-022-05492-w

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Gastric Cancer, December 2022
Gate On Date
Wed, 06/22/2022 - 12:15
Un-Gate On Date
Wed, 06/22/2022 - 12:15
Use ProPublica
CFC Schedule Remove Status
Wed, 06/22/2022 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article